ArticleInternational urology and nephrology2025
Role of 2D shear wave elastography in assessing chronic kidney disease and its correlation with point shear wave elastography and eGFR.
Article in International urology and nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The study was conducted with the aim of calculating renal stiffness through shear wave sonoelastography (SWE) in chronic kidney disease (CKD) and in normal kidneys, to find out a cut off value to differentiate between the two. This cross-sectional study included 80 participants (40 CKD patients and 40 subjects with normal renal function) with eGFR calculated using serum creatinine taken as a biochemical parameter. All participants underwent 2D and point SWE. Values obtained as young's modulus statistical analysis was done. CKD patients had higher mean 2D elasticity of 7.92 kPa (SD ± 1.94) and mean point elasticity of 7.93 kPa (SD ± 3.83) compared to the control group. At a cutoff point of > 5.2, Elast Q provides the reliable balance between sensitivity (95%) and specificity (97.5%) for predicting CKD. To conclude, Young's modulus values derived by 2D and point SWE found to be greater in diseased kidneys than healthy kidneys. 2D SWE (Elast Q) outperforms point SWE (Elast PQ) in predicting CKD due to its higher area under the curve, better sensitivity, specificity making it more reliable diagnostic tool for CKD.
Indexed as
Identifiers
40163268What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.